73387-59-4

Basic information

• Product Name: 1H-Pyrazole, 1-methyl-3-(4-nitrophenyl)-
• CAS NO: 73387-59-4
• Molecular Formula: C10H9N3O2
• Molecular Weight: 203.2
• Mol File: 73387-59-4.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: 1H-Pyrazole, 1-methyl-3-(4-nitrophenyl)-(CAS DataBase Reference)
• NIST Chemistry Reference: 1H-Pyrazole, 1-methyl-3-(4-nitrophenyl)-(73387-59-4)
• EPA Substance Registry System: 1H-Pyrazole, 1-methyl-3-(4-nitrophenyl)-(73387-59-4)

Safety Data

• Hazardous Substances Data: 73387-59-4(Hazardous Substances Data)

Usage

Compound type

pyrazole derivative

Contains

a methyl group and a 4-nitrophenyl group

Usage

commonly used in organic synthesis as a building block for the preparation of various pharmaceuticals and agrochemicals

Unique features

its unique structure and chemical properties make it useful in the development of new drugs and other biologically active compounds

Potential uses

may also have some potential uses in the field of material science and other industrial applications.

Upstream product

• 100-19-6 (4-nitrophenyl)ethanone 
• 68760-11-2 (Z)-3-(dimethylamino)-1-(4-nitrophenyl)prop-2-en-1-one 
• 60-34-4 methylhydrazine 
• 20583-31-7 3-(4-nitrophenyl)-1H-pyrazole 
• 74-88-4 methyl iodide 

Downstream Products

• 916766-82-0 4-(1-methyl-1H-pyrazol-3-yl)aniline 
• 1142275-19-1 C₁₂H₁₁N₃O₃ 
• 927653-45-0 4-bromo-1-methyl-3-(4-nitrophenyl)-1H-pyrazole 

Relevant articles and documents

NOVEL FUSED PYRIDINE DERIVATIVES USEFUL AS FAK/AURORA KINASE INHIBITORS

This invention relates to certain novel pyrimidine derivatives of the Formula (I). The invention also relates to process for the preparation of the compound of the formula (I), pharmaceutical agents or compositions containing the compound or a method of using the compound for the treatment of proliferative diseases, such as cancer.

Two convenient regioselective syntheses of 1-N-alkyl-3-aryl-4-[pyrimidin-4-yl]-pyrazoles

Two regioselective synthetic routes for 1-N-alkyl-3-aryl-4-[pyrimidin-4-yl]-pyrazoles of generic formula 1 were developed. These highly efficient and scalable routes circumvent the generally observed poor regioselectivity for the pyrazole alkylation.